JP3365091B2 - Lipid extraction method - Google Patents

Lipid extraction method

Info

Publication number
JP3365091B2
JP3365091B2 JP26177394A JP26177394A JP3365091B2 JP 3365091 B2 JP3365091 B2 JP 3365091B2 JP 26177394 A JP26177394 A JP 26177394A JP 26177394 A JP26177394 A JP 26177394A JP 3365091 B2 JP3365091 B2 JP 3365091B2
Authority
JP
Japan
Prior art keywords
lipid
organic solvent
antioxidant
blood
extraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP26177394A
Other languages
Japanese (ja)
Other versions
JPH08101200A (en
Inventor
稔 鹿島
善郎 中野
和也 守沢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
NOF Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOF Corp filed Critical NOF Corp
Priority to JP26177394A priority Critical patent/JP3365091B2/en
Publication of JPH08101200A publication Critical patent/JPH08101200A/en
Application granted granted Critical
Publication of JP3365091B2 publication Critical patent/JP3365091B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Extraction Or Liquid Replacement (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、血液成分に含まれる脂
質の簡便、迅速な抽出方法に関する。なお、本発明にお
いて、血液成分とは、全血、血漿、血球などである。血
漿とは、全血の遠心分離(3000回転/分)後の上清
である。血球とは遠心分離(3000回転/分)後の沈
殿である。
TECHNICAL FIELD The present invention relates to a simple and rapid method for extracting lipids contained in blood components. In the present invention, the blood component is whole blood, plasma, blood cells and the like. Plasma is the supernatant of whole blood after centrifugation (3000 rpm). Blood cells are the precipitates after centrifugation (3000 rpm).

【0002】[0002]

【従来の技術】一般に、脂質を含有する試料中から脂質
を抽出する方法としては、クロロホルム−メタノール混
合物等の溶媒を試料の数倍容加えて抽出するフォルヒ
(Folch)法や、クロロホルム−メタノール−水混
合物等の溶媒を数倍容加えて抽出するブライ−ダイアー
(Bligh−Dyer)法等が行なわれている。
2. Description of the Related Art Generally, as a method for extracting a lipid from a sample containing a lipid, the Folch method in which a solvent such as a chloroform-methanol mixture is added in an amount several times the volume of the sample, and the chloroform-methanol- A Bligh-Dyer method in which a solvent such as a water mixture is added in several volumes and extraction is performed is performed.

【0003】ところで、医学分野においては、血液成分
からその含有する脂質を抽出し、さらにその脂質の中の
過酸化脂質を正確に定量する必要性が生ずることが多
く、その場合の脂質の抽出方法としては、通常「脂質研
究法:生化学実験法5」(山川民夫ら、東京化学同人社
発行)などに記載されている方法が用いられていた。
By the way, in the medical field, it is often necessary to extract lipids contained in blood components and to accurately quantify lipid peroxides in the lipids. The method described in "Lipid Research Method: Biochemistry Experimental Method 5" (Tamio Yamakawa et al., Published by Tokyo Kagaku Dojinsha Co., Ltd.) was usually used as the above.

【0004】すなわち、まず血液を酸性クエン酸−デキ
ストロース混合物中に入れ遠心分離した後、沈殿した血
球の層を乱さないように、パスツールピペットを用いて
上澄みの血漿を採取し、ついで沈殿した血球の層をさら
に生理食塩水に懸濁し、再び遠心分離して注意深く上澄
みを採取し、先の血漿と合わせる。さらに、その残分を
再び生理食塩水に懸濁せしめて懸濁液とし、先の血漿と
それぞれ別個にメタノール−クロロホルム混合物を加え
て脂質を抽出し、それらを合計して脂質とする。
That is, first, blood is put into an acidic citric acid-dextrose mixture and centrifuged, and then supernatant plasma is collected using a Pasteur pipette so as not to disturb the layer of the precipitated blood cells, and then the precipitated blood cells are collected. Layer is further suspended in physiological saline, centrifuged again, and the supernatant is carefully collected and combined with the above plasma. Further, the residue is resuspended in physiological saline to form a suspension, and a methanol-chloroform mixture is added separately from the above plasma to extract lipids, and these are combined to obtain lipids.

【0005】[0005]

【発明が解決しようとする課題】このような従来の血液
成分からの脂質の抽出方法においては、抽出操作中に水
が存在するため、水を混入しないように脂質が溶けてい
る有機溶媒層だけをとりだすなど操作が煩雑であり、最
終的に無水硫酸ナトリウムを入れて脱水するため抽出操
作に時間がかかる。そのため、操作中に水の存在が無
く、しかも簡便、迅速な脂質抽出法の開発が望まれてい
る。本発明の目的は、血液成分に含まれる脂質を簡便に
効率よく抽出する方法、特に過酸化脂質を定量的に抽出
する方法を提供することである。
In such a conventional method for extracting lipids from blood components, since water is present during the extraction operation, only the organic solvent layer in which the lipids are dissolved so that water is not mixed The operation such as taking out is complicated and the extraction operation is time-consuming because it is finally dehydrated by adding anhydrous sodium sulfate. Therefore, there is a demand for the development of a simple and rapid lipid extraction method in which there is no water during the operation. An object of the present invention is to provide a method for easily and efficiently extracting lipids contained in blood components, particularly a method for quantitatively extracting lipid peroxides.

【0006】[0006]

【課題を解決するための手段】本発明者らは、これら従
来の抽出方法の欠点を解消し、血液成分に含まれている
脂質を簡便に、迅速に、かつ効率よく抽出する方法を得
ること、さらには過酸化脂質を正確に定量することを目
的として鋭意研究した結果、まず血液成分を凍結乾燥し
て、抽出操作を煩雑にする水分を除去した後、有機溶媒
で抽出することにより、その目的を達し得ることを知
り、本発明を完成するに至った。
[Means for Solving the Problems] The present inventors have solved the drawbacks of these conventional extraction methods and obtained a method for extracting lipids contained in blood components simply, quickly and efficiently. , Furthermore, as a result of earnest research for the purpose of accurately quantifying lipid peroxide, first, by freeze-drying blood components to remove water that complicates the extraction procedure, and then by extracting with an organic solvent, Knowing that the object can be achieved, the present invention has been completed.

【0007】すなわち、本発明は、血液成分を凍結乾燥
した後、有機溶媒で抽出することを特徴とする脂質の抽
出方法に関する。
That is, the present invention relates to a method for extracting lipids, which comprises freeze-drying a blood component and then extracting it with an organic solvent.

【0008】本発明において、抽出の対象となる脂質と
は、炭素数10〜40の長鎖炭化水素、炭素数10〜5
0の高級アルコール、炭素数8〜35のアルデヒド、炭
素数6〜24の脂肪酸、グリセリドとその誘導体、ろう
(ワックス)エステル、リン脂質、糖脂質、硫脂質、脂
溶性であるビタミンA,D,E,Kやその誘導体、カロ
チノイド、ステロールなどである。
In the present invention, the lipids to be extracted are long-chain hydrocarbons having 10 to 40 carbon atoms and 10 to 5 carbon atoms.
0 higher alcohols, C8-35 aldehydes, C6-24 fatty acids, glycerides and their derivatives, wax esters, phospholipids, glycolipids, sulphur lipids, fat-soluble vitamins A, D, E, K and its derivatives, carotenoids, sterols and the like.

【0009】本発明において用いられる有機溶媒として
は、ヘキサン、石油エーテル、ベンゼン、クロロホルム
などの極性の低い溶媒と、アセトン、エタノール、メタ
ノール、2−プロパノールなどの極性の高い溶媒とを、
容量比で(5:1)〜(1:5)の割合になるように混
合したものである。中でも血漿からの抽出は、クロロホ
ルムとメタノールとを容量比で(2:1)になるように
混合したもの、血球あるいは血液からの抽出は、クロロ
ホルムと2−プロパノールとを容量比で(7:11)に
なるように混合したものが特に好ましい。有機溶媒の使
用量としては、血液成分と等量以上あればよく特に2〜
10倍量が好ましい。
As the organic solvent used in the present invention, a solvent having a low polarity such as hexane, petroleum ether, benzene and chloroform and a solvent having a high polarity such as acetone, ethanol, methanol and 2-propanol are used.
It is a mixture in which the volume ratio is (5: 1) to (1: 5). Among them, extraction from plasma was performed by mixing chloroform and methanol at a volume ratio of (2: 1), and extraction from blood cells or blood was performed by mixing chloroform and 2-propanol at a volume ratio (7:11). It is particularly preferable to use a mixture such that The amount of the organic solvent used may be equal to or more than that of the blood component, particularly 2 to
A 10-fold amount is preferable.

【0010】本発明において用いられる抗酸化剤は、抽
出操作中に生ずる過酸化脂質の生成を抑制するため有機
溶媒中に添加されるもので、その種類としては、ラジカ
ル捕捉作用を有し、有機溶媒に完全に溶解するものであ
れば良く、たとえば、フェノール系化合物などの合成抗
酸化剤、トコフェロールなどの天然抗酸化剤であるが、
特にt−ブチルヒドロキシトルエンが好ましい。抗酸化
剤の添加量としては、有機溶媒に対して0.001〜
0.01%であるが、特に0.001〜0.005%の
範囲が好ましい。
The antioxidant used in the present invention is added to an organic solvent in order to suppress the production of lipid peroxides generated during the extraction operation. As long as it is completely soluble in a solvent, for example, synthetic antioxidants such as phenolic compounds, natural antioxidants such as tocopherol,
Particularly preferred is t-butylhydroxytoluene. The amount of the antioxidant added is 0.001 to the organic solvent.
Although it is 0.01%, a range of 0.001 to 0.005% is particularly preferable.

【0011】本発明における凍結乾燥は、試料を液体窒
素などで−20℃以下に凍らせた後、1時間以上減圧下
に乾燥することにより行なわれる。
The freeze-drying in the present invention is carried out by freezing the sample to -20 ° C or lower with liquid nitrogen or the like and then drying it under reduced pressure for 1 hour or more.

【0012】[0012]

【発明の効果】本発明の抽出方法によれば、血液成分か
ら簡便かつ迅速に脂質を抽出することができ、さらに有
機溶媒中に抗酸化剤を含有する場合は、特に過酸化脂質
の生成しやすい試料からの抽出に用いてその生成を抑制
することができる。
EFFECT OF THE INVENTION According to the extraction method of the present invention, lipids can be extracted from blood components simply and quickly. Further, when an antioxidant is contained in the organic solvent, lipid peroxides are particularly produced. It can be used for extraction from a simple sample and its generation can be suppressed.

【0013】[0013]

【実施例、比較例】以下、実施例、比較例により、本発
明をさらに具体的に説明する。なお、これらの各例にお
いて、検査対象者としたのは、いずれの場合も同一の健
常人A〜Eの5名であった。
EXAMPLES, COMPARATIVE EXAMPLES The present invention will be described in more detail with reference to Examples and Comparative Examples. In each of these examples, the subjects to be inspected were 5 healthy subjects A to E who were the same in all cases.

【0014】実施例1−1(血漿からの抗酸化剤を含ま
ない有機溶媒による脂質の抽出) それぞれの検査対象者から採取した血液各5mlを、遠
心分離機により3000回転/分で10分間遠心分離
し、上澄みとしての血漿を得た。この血漿1mlを試験
管に入れ液体窒素で凍らせた後、12時間凍結乾燥して
完全に水を除去した。
Example 1-1 (Extraction of Lipid from Plasma with Antioxidant-Free Organic Solvent) 5 ml of blood collected from each test subject was centrifuged for 10 minutes at 3000 rpm with a centrifuge. Separation was performed to obtain plasma as a supernatant. 1 ml of this plasma was placed in a test tube, frozen with liquid nitrogen, and then freeze-dried for 12 hours to completely remove water.

【0015】得られた凍結乾燥物にクロロホルム−メタ
ノール混合物(容量比2:1)6mlを加え、30秒間
振とう後上記と同じ条件で遠心分離し、上澄みを窒素気
流下で濃縮乾固して1回目脂質抽出物を得た。同様に、
この操作をさらに2回繰り返し、それぞれ2回目脂質抽
出物、3回目脂質抽出物を得た。得られた脂質抽出物
は、それぞれデシケーター中で恒量になるまで減圧下で
乾固して重量を測定し、その合計量を脂質含量として表
1に示した。
6 ml of a chloroform-methanol mixture (volume ratio 2: 1) was added to the lyophilized product obtained, shaken for 30 seconds, centrifuged under the same conditions as above, and the supernatant was concentrated to dryness under a nitrogen stream. A first-time lipid extract was obtained. Similarly,
This operation was repeated twice more to obtain a second lipid extract and a third lipid extract, respectively. The obtained lipid extracts were dried under reduced pressure in a desiccator until the weight became constant and weighed. The total amount is shown in Table 1 as a lipid content.

【0016】さらに、得られた脂質抽出物について、そ
の中の過酸化脂質量を化学発光検出−高速液体クロマト
グラフィー法により測定し、フォスファチジルコリンヒ
ドロペルオキシドとしてあわせて表1に示した。
Further, the amount of lipid peroxide in the obtained lipid extract was measured by chemiluminescence detection-high performance liquid chromatography, and the results are shown in Table 1 as phosphatidylcholine hydroperoxide.

【0017】その測定の方法は、以下のとおりである。
すなわち、得られた脂質をクロロホルム−メタノール混
合物(容量比1:1)50μlに溶解し、そのうちの2
0μlを高速液体クロマトグラフィーに注入する。化学
発光検出および高速液体クロマトグラフィーの条件は次
に示した。 (化学発光検出) 発光試薬:チトクロムc(1μg/ml)とルミノール
(10μg/ml)を溶解した50mMホウ酸緩衝液
(pH9.3) 化学発光検出器:東北電子産業社製、ケミルミネッセン
スアナライザーOX−7型 (高速液体クロマトグラフィー) カラム:順相系シリカ−NH2、4.6×250mm、
日本分光社製 移動相:ヘキサン:2−プロパノール:メタノール:水
=5:7:2:1
The measuring method is as follows.
That is, the obtained lipid was dissolved in 50 μl of a chloroform-methanol mixture (volume ratio 1: 1), and 2
Inject 0 μl for high performance liquid chromatography. The conditions for chemiluminescence detection and high performance liquid chromatography are shown below. (Chemical luminescence detection) Luminescent reagent: Cytochrome c (1 μg / ml) and luminol (10 μg / ml) dissolved in 50 mM borate buffer (pH 9.3) Chemiluminescence detector: Tohoku Denshi Sangyo KK, Chemiluminescence Analyzer OX -7 type (high performance liquid chromatography) column: normal phase silica-NH 2 , 4.6 × 250 mm,
JASCO Corporation mobile phase: hexane: 2-propanol: methanol: water = 5: 7: 2: 1

【0018】実施例2−1(血漿からの抗酸化剤を含む
有機溶媒による脂質の抽出) 実施例1−1において、有機溶媒としてのクロロホルム
−メタノール混合物(容量比2:1)6mlに代えて、
この配合にさらにt−ブチルヒドロキシトルエン0.0
02%を含有せしめた混合物6mlを用いる以外は、実
施例1−1に準じて実施した。結果は表1に示した。
Example 2-1 (Extraction of Lipid from Plasma with Organic Solvent Containing Antioxidant) In Example 1-1, 6 ml of chloroform-methanol mixture (volume ratio 2: 1) was used as the organic solvent. ,
In addition to this formulation, t-butyl hydroxytoluene 0.0
The procedure was as in Example 1-1, except that 6 ml of the mixture containing 02% was used. The results are shown in Table 1.

【0019】比較例1(血漿からの抗酸化剤を含む有機
溶媒による従来法の脂質の抽出) それぞれの検査対象者から採取した血液各5mlを、遠
心分離機により3000回転/分で10分間遠心分離
し、上澄みとしての血漿を得た。
Comparative Example 1 (Extraction of Lipid from Plasma by Organic Method Using Antioxidant-Containing Organic Solvent) 5 ml of blood collected from each test subject was centrifuged at 3000 rpm for 10 minutes by a centrifuge. Separation was performed to obtain plasma as a supernatant.

【0020】この血漿1mlにクロロホルム−メタノー
ル混合物(容量比2:1、t−ブチルヒドロキシトルエ
ン0.002%を含む)6mlを加え、30秒間振とう
後上記と同じ条件で遠心分離し、クロロホルム層と水−
メタノール層と残分とに分け、まずクロロホルム層に無
水硫酸ナトリウムを加え1昼夜放置して脱水後濾過し、
瀘液を窒素気流下で濃縮乾固して1回目脂質抽出物を得
た。さらに、水−メタノール層と残分とから同様の操作
を続けて2回行ない、それぞれ2回目脂質抽出物、3回
目脂質抽出物を得た。得られた脂質抽出物は、実施例1
−1に準じて処理しその結果は表1に示した。
To 1 ml of this plasma was added 6 ml of a chloroform-methanol mixture (volume ratio 2: 1, containing t-butylhydroxytoluene 0.002%), and the mixture was shaken for 30 seconds and then centrifuged under the same conditions as above to form a chloroform layer. And water −
Separate the methanol layer and the residue, add anhydrous sodium sulfate to the chloroform layer, leave it for one day and leave it for dehydration, and then filter.
The filtrate was concentrated to dryness under a nitrogen stream to obtain a lipid extract for the first time. Further, the same operation was continued twice from the water-methanol layer and the residue to obtain a second lipid extract and a third lipid extract, respectively. The lipid extract obtained is from Example 1.
It processed according to -1, and the result is shown in Table 1.

【0021】[0021]

【表1】 [Table 1]

【0022】実施例1−2(血球からの抗酸化剤を含ま
ない有機溶媒による脂質の抽出) それぞれの検査対象者から採取した血液各5mlを、遠
心分離機により3000回転/分で10分間遠心分離
し、沈殿としての血球を得た。この血球0.5mlに蒸
留水2.5mlを加えて溶血させた後、実施例1−1に
準じて凍結乾燥して完全に水を除去した。
Example 1-2 (Extraction of Lipid from Blood Cells with Organic Solvent without Antioxidant) 5 ml of blood collected from each test subject was centrifuged for 10 minutes at 3000 rpm with a centrifuge. Separation was performed to obtain blood cells as a precipitate. 2.5 ml of distilled water was added to 0.5 ml of these blood cells to hemolyze them, and then freeze-dried according to Example 1-1 to completely remove water.

【0023】得られた凍結乾燥物に2−プロパノール
(0.1mM、EDTA溶液)11ml、クロロホルム
7mlを加え、4℃で30分間振とう後上記と同じ条件
で遠心分離し、上澄みを窒素気流下で濃縮乾固して1回
目脂質抽出物を得た。同様に、この操作をさらに2回繰
り返し、それぞれ2回目脂質抽出物、3回目脂質抽出物
を得た。得られた脂質抽出物は、実施例1−1に準じて
処理しその結果は表2に示した。
2-Propanol (0.1 mM, EDTA solution) (11 ml) and chloroform (7 ml) were added to the obtained freeze-dried product, and the mixture was shaken at 4 ° C. for 30 minutes and then centrifuged under the same conditions as described above. The mixture was concentrated to dryness with to obtain a first lipid extract. Similarly, this operation was repeated twice more to obtain a second lipid extract and a third lipid extract, respectively. The obtained lipid extract was treated according to Example 1-1, and the results are shown in Table 2.

【0024】さらに、得られた脂質抽出物について、そ
の中の過酸化脂質量を実施例1−1に準じて測定し、フ
ォスファチジルコリンヒドロペルオキシドおよびフォス
ファチジルエタノールアミンヒドロペルオキシドとして
あわせて表2に示した。
Further, the amount of lipid peroxide in the obtained lipid extract was measured according to Example 1-1, and the results were also shown as phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide. Shown in 2.

【0025】実施例2−2(血球からの抗酸化剤を含む
有機溶媒による脂質の抽出) 実施例1−2において、有機溶媒としての2−プロパノ
ール(0.1mM、EDTA溶液)11mlに代えて、
この配合にさらにt−ブチルヒドロキシトルエン0.0
02%を含有せしめた混合物11mlを用いる以外は、
実施例1−2に準じて実施した。結果は表2に示した。
Example 2-2 (Extraction of Lipid from Blood Cells with Organic Solvent Containing Antioxidant) In Example 1-2, 11 ml of 2-propanol (0.1 mM, EDTA solution) as the organic solvent was used instead. ,
In addition to this formulation, t-butyl hydroxytoluene 0.0
Except using 11 ml of a mixture containing 02%
It carried out according to Example 1-2. The results are shown in Table 2.

【0026】比較例2(血球からの抗酸化剤を含む有機
溶媒による従来法の脂質の抽出) それぞれの検査対象者から採取した血液各5mlを、遠
心分離機により3000回転/分で10分間遠心分離
し、沈殿としての血球を得た。
Comparative Example 2 (Extraction of Lipids from Blood Cells by Organic Method Using Antioxidant-Containing Organic Solvent) 5 ml of blood collected from each test subject was centrifuged at 3000 rpm for 10 minutes by a centrifuge. Separation was performed to obtain blood cells as a precipitate.

【0027】この血球0.5mlに蒸留水2.5mlを
加えて溶血させた後、2−プロパノール(0.1mM、
EDTA溶液,t−ブチルヒドロキシトルエン0.00
2%を含む)11ml、クロロホルム7mlを加え、4
℃で30分間振とう後上記と同じ条件で遠心分離し、ク
ロロホルム層と水−2−プロパノール層と残分とに分
け、まずクロロホルム層に無水硫酸ナトリウムを加え1
昼夜放置して脱水後瀘過し、瀘液を窒素気流下で濃縮乾
固して1回目脂質抽出物を得た。さらに、水−2−プロ
パノール層と残分とから同様の操作を続けて2回行な
い、それぞれ2回目脂質抽出物、3回目脂質抽出物を得
た。得られた脂質抽出物は、実施例1−1に準じて処理
しその結果は表2に示した。
2.5 ml of distilled water was added to 0.5 ml of the blood cells to cause hemolysis, and then 2-propanol (0.1 mM,
EDTA solution, t-butylhydroxytoluene 0.00
11 ml (including 2%) and 7 ml of chloroform were added, and 4
After shaking at ℃ for 30 minutes, it was centrifuged under the same conditions as above to separate into a chloroform layer, a water-2-propanol layer and a residue. First, anhydrous sodium sulfate was added to the chloroform layer to obtain 1
The mixture was left standing for 24 hours, dehydrated and filtered, and the filtrate was concentrated to dryness under a nitrogen stream to obtain a first lipid extract. Further, the same operation was continued twice from the water-2-propanol layer and the residue to obtain a second lipid extract and a third lipid extract, respectively. The obtained lipid extract was treated according to Example 1-1, and the results are shown in Table 2.

【0028】[0028]

【表2】 [Table 2]

【0029】実施例1−3(血液からの抗酸化剤を含ま
ない有機溶媒による脂質の抽出) それぞれの検査対象者から採取した血液各0.5mlに
蒸留水2.5mlを加えて溶血させた後、実施例1−1
に準じて凍結乾燥して完全に水を除去した。
Example 1-3 (Extraction of Lipid from Blood by Organic Solvent without Antioxidant) 2.5 ml of distilled water was added to 0.5 ml of blood collected from each subject to be hemolyzed. After that, Example 1-1
Water was completely removed by freeze-drying according to.

【0030】得られた凍結乾燥物に2−プロパノール
(0.1mM、EDTA溶液)11ml、クロロホルム
7mlを加え、4℃で30分間振とう後実施例1−1と
同じ条件で遠心分離し、上澄みを窒素気流下で濃縮乾固
して1回目脂質抽出物を得た。同様に、この操作をさら
に2回繰り返し、それぞれ2回目脂質抽出物、3回目脂
質抽出物を得た。得られた脂質抽出物は、実施例1−1
に準じて処理しその結果は表3に示した。
2-Propanol (0.1 mM, EDTA solution) (11 ml) and chloroform (7 ml) were added to the obtained freeze-dried product, and the mixture was shaken at 4 ° C. for 30 minutes and then centrifuged under the same conditions as in Example 1-1 to obtain a supernatant. Was concentrated to dryness under a nitrogen stream to obtain a first lipid extract. Similarly, this operation was repeated twice more to obtain a second lipid extract and a third lipid extract, respectively. The obtained lipid extract was obtained from Example 1-1.
The results are shown in Table 3.

【0031】さらに、得られた脂質抽出物について、そ
の中の過酸化脂質量を実施例1−1に準じて測定し、フ
ォスファチジルコリンヒドロペルオキシドおよびフォス
ファチジルエタノールアミンヒドロペルオキシドとして
あわせて表3に示した。
Further, the lipid extract thus obtained was measured for the amount of lipid peroxide in accordance with Example 1-1, and the results were also shown as phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide. Shown in 3.

【0032】実施例2−3(血液からの抗酸化剤を含む
有機溶媒による脂質の抽出) 実施例1−3において、有機溶媒としての2−プロパノ
ール(0.1mM、EDTA溶液)11mlに代えて、
この配合にさらにt−ブチルヒドロキシトルエン0.0
02%を含有せしめた混合物11mlを用いる以外は、
実施例1−3に準じて実施した。結果は表3に示した。
Example 2-3 (Extraction of Lipid from Blood with Organic Solvent Containing Antioxidant) In Example 1-3, 2-propanol (0.1 mM, EDTA solution) as an organic solvent was replaced with 11 ml. ,
In addition to this formulation, t-butyl hydroxytoluene 0.0
Except using 11 ml of a mixture containing 02%
It carried out according to Example 1-3. The results are shown in Table 3.

【0033】比較例3(血液からの抗酸化剤を含む有機
溶媒による従来法の脂質の抽出) それぞれの検査対象者から採取した血液各0.5mlに
蒸留水2.5mlを加えて溶血させた後、2−プロパノ
ール(0.1mM、EDTA溶液,t−ブチルヒドロキ
シトルエン0.002%を含む)11ml、クロロホル
ム7mlを加え、4℃で30分間振とう後実施例1−1
と同じ条件で遠心分離し、クロロホルム層と水−2−プ
ロパノール層と残分とに分け、まずクロロホルム層に無
水硫酸ナトリウムを加え1昼夜放置して脱水後濾過し、
瀘液を窒素気流下で濃縮乾固して1回目脂質抽出物を得
た。さらに、水−2−プロパノール層と残分とから同様
の操作を続けて2回行ない、それぞれ2回目脂質抽出
物、3回目脂質抽出物を得た。得られた脂質抽出物は、
実施例1−1に準じて処理しその結果は表3に示した。
Comparative Example 3 (Extraction of Lipid from Blood by Organic Solvent Containing Antioxidant by Conventional Method) 2.5 ml of distilled water was added to 0.5 ml of blood collected from each subject to be hemolyzed. Then, 11 ml of 2-propanol (0.1 mM, EDTA solution, containing 0.002% of t-butylhydroxytoluene) and 7 ml of chloroform were added, and the mixture was shaken at 4 ° C. for 30 minutes.
Centrifuge under the same conditions as above, and separate into chloroform layer, water-2-propanol layer and residue. First, add anhydrous sodium sulfate to the chloroform layer, leave it for 24 hours, dehydrate and filter,
The filtrate was concentrated to dryness under a nitrogen stream to obtain a lipid extract for the first time. Further, the same operation was continued twice from the water-2-propanol layer and the residue to obtain a second lipid extract and a third lipid extract, respectively. The obtained lipid extract is
The treatment was carried out according to Example 1-1, and the results are shown in Table 3.

【0034】[0034]

【表3】 [Table 3]

【0035】以上の表1〜表3の結果から、次のことが
明らかである。 (1)血液成分(血漿、血球、血液の各成分を含む)中
の脂質含量については、前もって血液成分を凍結乾燥す
る本発明の方法の方が、有機溶媒中に抗酸化剤を含まな
い場合(実施例1−1,1−2,1−3)も、また抗酸
化剤を含む場合(実施例2−1,2−2,2−3)もい
ずれの場合も、従来の凍結乾燥を行なわない比較例の場
合に比べて、脂質の含量が格段に多く凍結乾燥の効果が
明らかに示されている。なお、この場合有機溶媒中に抗
酸化剤を含まない場合と抗酸化剤を含む場合との間に
は、大きな差はみられない。
From the results of Tables 1 to 3 above, the following is clear. (1) Regarding the lipid content in blood components (including plasma, blood cells, and blood components), when the method of the present invention in which the blood components are freeze-dried in advance does not contain an antioxidant in the organic solvent In both cases (Examples 1-1, 1-2, 1-3) and also in the case of containing an antioxidant (Examples 2-1-2-2, 2-3), conventional freeze-drying was performed. The effect of freeze-drying is clearly shown in comparison with the case of the comparative example in which the lipid content is much higher. In this case, no significant difference is observed between the case where the organic solvent does not contain the antioxidant and the case where the organic solvent contains the antioxidant.

【0036】(2)血液成分中の過酸化脂質含量につい
ては、フォスファチジルコリンヒドロペルオキシド、フ
ォスファチジルエタノールアミンヒドロペルオキシドの
いずれについても、有機溶媒中に抗酸化剤を含まない場
合に比べて、抗酸化剤を含む場合の方が、過酸化脂質の
含量が格段に少なく抗酸化剤の効果が明らかに示されて
いる。
(2) Regarding the content of lipid peroxide in blood components, both phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide were compared with the case where no antioxidant was contained in the organic solvent. In the case of containing an antioxidant, the content of lipid peroxide is much lower, and the effect of the antioxidant is clearly shown.

【0037】また、実施例2−1,2−2,2−3の場
合と対応する比較例1,2,3の場合とを比較してみる
に、この両者は、それぞれ有機溶媒、抗酸化剤として全
く同一のものを使用しているにもかかわらず、実施例2
−1,2−2,2−3の場合の方が明らかに過酸化脂質
の含量が少なく、凍結乾燥の効果が示されている。
Further, comparing the cases of Examples 2-1, 2-2, and 2-3 with the corresponding cases of Comparative Examples 1, 2, and 3, these two are respectively an organic solvent and an antioxidant. Example 2 in spite of using the exact same agent
In the cases of -1, 2, 2 and 2-3, the content of lipid peroxide is obviously smaller, and the effect of freeze-drying is shown.

【0038】さらにまた、この凍結乾燥の効果は、抗酸
化剤を含まない場合と、抗酸化剤を含む比較例の場合と
がほぼ同等の数値を示していることからみて、凍結乾燥
を行なえば、抗酸化剤を含まなくても、比較例の場合と
ほぼ同等の効果を示すことからも確認することができ
る。
Further, regarding the effect of this freeze-drying, when the freeze-drying is performed, it can be seen from the fact that the values of the case where the antioxidant is not contained and the case of the comparative example which contains the antioxidant are almost the same. It can also be confirmed from the fact that the effect is almost the same as that of the comparative example even if the antioxidant is not included.

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 血液成分を凍結乾燥した後、有機溶媒で
抽出することを特徴とする脂質の抽出方法。
1. A method for extracting lipids, which comprises freeze-drying a blood component and then extracting it with an organic solvent.
【請求項2】 有機溶媒が抗酸化剤を含むものである請
求項1記載の抽出方法。
2. The extraction method according to claim 1, wherein the organic solvent contains an antioxidant.
JP26177394A 1994-09-30 1994-09-30 Lipid extraction method Expired - Fee Related JP3365091B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26177394A JP3365091B2 (en) 1994-09-30 1994-09-30 Lipid extraction method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26177394A JP3365091B2 (en) 1994-09-30 1994-09-30 Lipid extraction method

Publications (2)

Publication Number Publication Date
JPH08101200A JPH08101200A (en) 1996-04-16
JP3365091B2 true JP3365091B2 (en) 2003-01-08

Family

ID=17366503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26177394A Expired - Fee Related JP3365091B2 (en) 1994-09-30 1994-09-30 Lipid extraction method

Country Status (1)

Country Link
JP (1) JP3365091B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001108688A (en) * 1999-10-07 2001-04-20 Dainippon Seiki:Kk Device for automatically extracting component substance in liquid sample, device for automatically measuring concentration and method for extracting component substance in liquid sample

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11609043B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11740019B2 (en) 2019-03-14 2023-08-29 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11747082B2 (en) 2019-03-14 2023-09-05 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11815311B2 (en) 2019-03-14 2023-11-14 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11994343B2 (en) 2019-03-14 2024-05-28 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use

Also Published As

Publication number Publication date
JPH08101200A (en) 1996-04-16

Similar Documents

Publication Publication Date Title
Kontush et al. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein.
Broekhuyse Quantitative two-dimensional thin-layer chromatography of blood phospholipids
Burton et al. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?
Glavind Antioxidants in animal tissue
Burton et al. A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios
Buttriss et al. [15] High-performance liquid chromatography methods for vitamin E in tissues
Dodge et al. Autoxidation as a cause of altered lipid distribution in extracts from human red cells
Lang et al. Quantitative determination of vitamin E and oxidized and reduced coenzyme Q by high-performance liquid chromatography with in-line ultraviolet and electrochemical detection
Glover et al. Sterol metabolism. 3. The distribution and transport of sterols across the intestinal mucosa of the guinea pig
Holmouist et al. Comparison between the use of isopropanol and tetramethylurea for the solubilisation and quantitation of human serum very low density apollpoproteins
Johnson et al. Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1, 4-dihydropyridine binding
Vatassery et al. Determination of α-tocopherolquinone (vitamine E quinone) in human serum, platelets, and red cell membrane samples
Leray et al. Quantitative analysis of vitamin E, cholesterol and phospholipid fatty acids in a single aliquot of human platelets and cultured endothelial cells
Adachi et al. Chemiluminescent determination of cholesterol hydroperoxides in human erythrocyte membrane
KR101548126B1 (en) Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability
Phillips The isolation of lysolecithin from human serum
JP3365091B2 (en) Lipid extraction method
Roubal Oxidative deterioration of flesh lipids of pacific cod (Gadus macrocephalus)
Kiyose et al. Change in the distribution of α-tocopherol stereoisomers in rats after intravenous administration
Papadimitriou et al. Antioxidant activity of polar extracts from olive oil and olive mill wastewaters: an EPR and photometric study
Carruthers et al. Phosphatides in mouse epidermis undergoing normal and abnormal growth changes
SATO et al. Phospholipid distribution in erythrocyte and plasma of the man, cow, pig and rabbit
Szeinberg et al. Investigation of the lipid content of normal and glucose-6-phosphate dehydrogenase deficient red cells
Adachi et al. Phosphatidylcholine hydroperoxide levels in human plasma are lower than previously reported
Slater et al. Procoagulant activity of partial thromboplastin (cephalin) reagent and its phospholipid composition

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081101

Year of fee payment: 6

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081101

Year of fee payment: 6

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091101

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101101

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101101

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111101

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111101

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121101

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131101

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees